BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ebrahim IO, Howard RS, Kopelman MD, Sharief MK, Williams AJ. The Hypocretin/Orexin System. J R Soc Med 2002;95:227-30. [DOI: 10.1177/014107680209500503] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Moreno-Ajona D, Hoffmann J. From basic mechanisms to therapeutic perspectives in cluster headache. Curr Opin Neurol 2022;35:336-42. [PMID: 35674077 DOI: 10.1097/WCO.0000000000001055] [Reference Citation Analysis]
2 Jékely G, Melzer S, Beets I, Kadow ICG, Koene J, Haddad S, Holden-Dye L. The long and the short of it - a perspective on peptidergic regulation of circuits and behaviour. J Exp Biol 2018;221:jeb166710. [PMID: 29439060 DOI: 10.1242/jeb.166710] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 10.5] [Reference Citation Analysis]
3 Sun M, Wang W, Li Q, Yuan T, Weng W. Orexin A may suppress inflammatory response in fibroblast-like synoviocytes. Biomedicine & Pharmacotherapy 2018;107:763-8. [DOI: 10.1016/j.biopha.2018.07.159] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
4 Kanbayashi T, Inoue Y, Kawanishi K, Takasaki H, Aizawa R, Takahashi K, Ogawa Y, Abe M, Hishikawa Y, Shimizu T. CSF hypocretin measures in patients with obstructive sleep apnea: CSF hypocretin measures in patients with obstructive sleep apnea. Journal of Sleep Research 2003;12:339-41. [DOI: 10.1046/j.0962-1105.2003.00373.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
5 Zhang H, Liang B, Li T, Zhou Y, Shang D, Du Z. Orexin A Suppresses Oxidized LDL Induced Endothelial Cell Inflammation via MAPK p38 and NF-κB Signaling Pathway: OREXIN A SUPPRESSES ENDOTHELIAL CELL INFLAMMATION. IUBMB Life 2018;70:961-8. [DOI: 10.1002/iub.1890] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
6 Rique GLN, Rique MC, Augusto de Souza Bonifácio T, Andrade MJO, dos Santos NA. Effects of vertical gastrectomy on sleep quality, eating behavior, and metabolic parameters in obese adults: a case study. Biological Rhythm Research. [DOI: 10.1080/09291016.2021.1906504] [Reference Citation Analysis]
7 Plazzi G, Clawges HM, Owens JA. Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy. Pediatric Neurology 2018;85:21-32. [DOI: 10.1016/j.pediatrneurol.2018.06.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
8 Wang L, He T, Wan B, Wang X, Zhang L. Orexin A ameliorates HBV X protein-induced cytotoxicity and inflammatory response in human hepatocytes. Artificial Cells, Nanomedicine, and Biotechnology 2019;47:2003-9. [DOI: 10.1080/21691401.2019.1614014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Anderson D. Narcolepsy: A clinical review. JAAPA 2021;34:20-5. [PMID: 34031309 DOI: 10.1097/01.JAA.0000750944.46705.36] [Reference Citation Analysis]
10 Marques TM, Van Rumund A, Kuiperij HB, Verbeek MM. Biomarkers in cerebrospinal fluid for synucleinopathies, tauopathies, and other neurodegenerative disorders. Cerebrospinal Fluid in Neurologic Disorders. Elsevier; 2018. pp. 99-113. [DOI: 10.1016/b978-0-12-804279-3.00007-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gabryelska A, Szmyd B, Maschauer EL, Roguski A, Canham R, Morrison I, Białasiewicz P, Riha RL. Utility of measuring CSF hypocretin-1 level in patients with suspected narcolepsy. Sleep Medicine 2020;71:48-51. [DOI: 10.1016/j.sleep.2020.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Ardeshiri MR, Hosseinmardi N, Akbari E. The effect of orexin 1 and orexin 2 receptors antagonisms in the basolateral amygdala on memory processing in a passive avoidance task. Physiology & Behavior 2017;174:42-8. [DOI: 10.1016/j.physbeh.2017.03.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
13 Vigerust DJ. The enigma of sleep. Future Neurology 2016;11:245-54. [DOI: 10.2217/fnl-2016-0017] [Reference Citation Analysis]
14 Dayan E, Sklerov M. Autonomic disorders in Parkinson disease: Disrupted hypothalamic connectivity as revealed from resting-state functional magnetic resonance imaging. Handb Clin Neurol 2021;182:211-22. [PMID: 34266593 DOI: 10.1016/B978-0-12-819973-2.00014-9] [Reference Citation Analysis]
15 Kollb-Sielecka M, Demolis P, Emmerich J, Markey G, Salmonson T, Haas M. The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use. Sleep Med 2017;33:125-9. [PMID: 28449891 DOI: 10.1016/j.sleep.2017.01.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
16 Evans BM. What Does Brain Damage Tell us about the Mechanisms of Sleep? J R Soc Med 2002;95:591-7. [DOI: 10.1177/014107680209501204] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Steinman L, Ahmed SS. Response to comment on “Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2”. Sci Transl Med 2015;7. [DOI: 10.1126/scitranslmed.aad6789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Bai Q, Pérez-Sánchez H, Shi Z, Li L, Shi D, Liu H, Yao X. Computational studies on horseshoe shape pocket of human orexin receptor type 2 and boat conformation of suvorexant by molecular dynamics simulations. Chem Biol Drug Des 2018;92:1221-31. [PMID: 29450984 DOI: 10.1111/cbdd.13181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 Sahbaz BD, Iyison NB. Neuropeptides as Ligands for GPCRs. In: Saravanan C, Biswas B, editors. Ligand. InTech; 2018. [DOI: 10.5772/intechopen.73504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Patel R, Quinn R, Silver J. Innovations in Insomnia Management: A Review of Current Approaches and Novel Targets Including Orexin Receptor Antagonists. American Journal of Therapeutics 2018;25:e28-35. [DOI: 10.1097/mjt.0000000000000670] [Reference Citation Analysis]
21 Pillai JA, Leverenz JB. Sleep and Neurodegeneration: A Critical Appraisal. Chest 2017;151:1375-86. [PMID: 28087304 DOI: 10.1016/j.chest.2017.01.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
22 Tacad DKM, Tovar AP, Richardson CE, Horn WF, Krishnan GP, Keim NL, Krishnan S. Satiety Associated with Calorie Restriction and Time-Restricted Feeding: Peripheral Hormones. Adv Nutr 2022;13:792-820. [PMID: 35191467 DOI: 10.1093/advances/nmac014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]